Zimmer Biomet (ZBH) has announced that it has received FDA 510(k) approval for its OsseoFit Stemless Shoulder System, intended for use in total shoulder replacements. This implant is engineered to align with natural humeral anatomy, ensuring an optimal anatomical fit while prioritizing the preservation of healthy bone. The OsseoFit Stemless Shoulder is set to become commercially available in the first quarter of 2025.
Brian Hatcher, President of SET & CMFT at Zimmer Biomet, stated, "The OsseoFit Stemless Shoulder System features an anatomically contoured implant focused on conserving bone and initially designed for stable fixation. Moreover, it integrates our exclusive OsseoTi Porous Metal Technology to enhance biological fixation."
